Companies: 10,795·Total market cap: $144.5T

Kodiak Sciences Inc.

Kodiak Sciences Inc.

KODNASDAQHealthcare● Active

$29.61

$-1.44(-4.64%)

Market Cap$1.6B

P/E Ratio—

52W High$47.84

52W Low$3.43

Avg Volume1.1M

Open$32.13

Beta2.21

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Kodiak Sciences Inc.（KOD）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · KOD · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-4.17Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding53.2MShares outstanding history

Next EarningsAug 12, 2026Est.Earnings history

探索 Kodiak Sciences Inc. 数据

分析师预测$64 · Buy

股息不分红

盈利EPS $-4.32-28.96%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$230.0M▼ 30.51% YoY

202320242025

FY 2025EPS$-4.32▼ 28.96% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$230.7MEPS: $-4.17View income statement →

分析师评级与目标价

Buy18 位分析师

Strong Buy

0

Buy

13

Hold

4

Sell

1

Strong Sell

0

12-Month Price Target

$56.00Low

$29.61Current

$63.75Avg Target上涨空间 115.30%

$80.00High

合计: 18 · 买入占比: 72.2%

根据过去 3 个月内 18 位华尔街分析师，KOD 共识评级为 Buy，12 个月平均目标价 $63.75 （较现价 $29.61 上涨空间 115.30%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Kodiak Sciences Inc.

$29.61-4.64%$1.6B #2

AnaptysBio, Inc.

$51.36+1.97%$2.2B #3

BridgeBio Oncology Therapeutics Inc.

$7.78-0.38%$623.2M #4

EyePoint Pharmaceuticals, Inc.

$11.45-2.80%$960.0M #5

Nurix Therapeutics, Inc.

$15.64+6.83%$1.4B #6

Oculis Holding AG

$10.71-4.46%$612.3M

股票表现

1D-4.64%

1W-11.53%

1M-27.80%

3M+19.11%

YTD+5.90%

1Y+613.49%

5Y+88.84%

关于 Kodiak Sciences Inc.

CEOVictor Perlroth

IPO DateOct 4, 2018

Employees109

CountryUS

Websitekodiak.com

Kodiak Sciences Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering, advancing, and bringing to market treatments for various conditions affecting th…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Kodiak Sciences Inc.（KOD）是 Biotechnology 行业的 Healthcare 类公司，于 Oct 4, 2018 在 NASDAQ 上市。截至最近交易日，KOD 股价为 $29.61，市值约为 $1.6B。过去12个月累计回报 +613.49%，年初至今回报 +5.90%。

根据 18 位华尔街分析师，Kodiak Sciences Inc. 股票共识评级为Buy，12个月平均目标价为 $63.75。2025 财年 Kodiak Sciences Inc. 营收 —，净利润 -$230.0M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Kodiak Sciences Inc.（KOD）股价为 $29.61，在 NASDAQ 上市，52周区间为 $3.43 – $47.84。

KOD 最新股价KOD quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议